LifeMD (LFMD) | Stock Overview & Key Data
LifeMD Performance Comparison
Stock Range
Today's Range
Low: $6.01
High: $6.36
on September 5, 2025
52 Week Range
Low: $3.99
High: $15.84
on October 30, 2024
on June 23, 2025
All-Time High: $33.02 on February 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$287.3M
EPS
-0.20
P/E Ratio (TTM)
-11.43
Forward P/E
-152.50
P/B Ratio
703.68
PEG Ratio
0.17
Div. Yield
N/A
ROE
543.53%
Beta
1.566
Debt to Equity
5,767.28
Financial Highlights
Profitability
Gross Margin
88.06%
Operating Margin
-1.46%
Profit Margin
-2.41%
Returns and Earnings
Return on Assets (TTM)
-1.85%
Return on Equity (TTM)
543.53%
EBITDA
$-371.0K
Net Income (TTM)
$-9.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$5.82
Quarterly Revenue Growth (YoY)
22.80%
Quarterly Earnings Growth (YoY)
22.81%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| LifeMD LFMD | 287.35M Small-cap | -2.10% | -48.82% | -49.83% | 21.44% | 15.87% | 26.51% | 135.80% | -3.04% |
| Veeva Systems VEEV | 44.12B Large-cap | 1.39% | -3.03% | -5.87% | 24.09% | 29.61% | 26.42% | 52.31% | 3.18% |
| Ge Healthcare GEHC | 34.58B Large-cap | 2.71% | 7.05% | 5.84% | -10.65% | -3.38% | -11.00% | 33.47% | 33.47% |
| 10x Genomics TXG | 1.74B Small-cap | -0.36% | 4.88% | 53.24% | 27.72% | -1.62% | -35.19% | -61.11% | -88.83% |
| Certara CERT | 1.72B Small-cap | -2.95% | 6.69% | -10.09% | -11.67% | -1.31% | -7.64% | -35.38% | -72.37% |
| Omnicell OMCL | 1.52B Small-cap | -1.47% | 5.28% | 4.02% | -15.10% | -27.55% | -29.10% | -69.52% | -55.32% |
Ownership & Short Interest
Insider Ownership
15.82%
Institutional Ownership
53.77%
Shares Short
6M
Short Ratio
2.68
Short % of Shares Outstanding
15.92%
Average 10-Day Volume
1M
Average 90-Day Volume
2M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LFMD's 52-week high and low?
- In the last 52 weeks, LifeMD reached a high of $15.84 (on June 23, 2025) and a low of $3.99 (on October 30, 2024).
- What is the market cap and P/E ratio for LFMD?
- Curious about LifeMD's size and valuation? Its market capitalization stands at 287.35M. When it comes to valuation, the P/E ratio (trailing twelve months) is -11.43, and the forward P/E (looking ahead) is -152.50.
- Does LFMD pay dividends? If so, what's the yield?
- As for dividends, LifeMD isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are LifeMD's main competitors or similar companies to consider before investing?
When looking at LifeMD, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Veeva Systems
VEEV44.12B Healthcare Health Information Services 26.42% 52.31% Ge Healthcare
GEHC34.58B Healthcare Health Information Services -11.00% 33.47% 10x Genomics
TXG1.74B Healthcare Health Information Services -35.19% -61.11% Certara
CERT1.72B Healthcare Health Information Services -7.64% -35.38% Omnicell
OMCL1.52B Healthcare Health Information Services -29.10% -69.52% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for LifeMD Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of LifeMD's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 543.53%, the Debt to Equity ratio from the most recent quarter is 5,767.28, and its Gross Profit Margin stands at 88.06%.
- What is the recent revenue and earnings growth for LFMD?
- Looking at LifeMD's growth, its revenue over the trailing twelve months (TTM) was $246M. Compared to the same quarter last year (YoY), quarterly revenue grew by 22.80%, and quarterly earnings saw a YoY growth of 22.81%.
- How much of LFMD stock is held by insiders and institutions?
- Wondering who owns LifeMD stock? Company insiders (like executives and directors) hold about 15.82% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 53.77%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.